BIOMAT Database Logo BIOMAT Database Logo

Proceedings: Controlled trial of D-penicillamine therapy in chronic active hepatitis. 1976

R B Stern, and S P Wilkinson, and R Williams

UI MeSH Term Description Entries
D010396 Penicillamine 3-Mercapto-D-valine. The most characteristic degradation product of the penicillin antibiotics. It is used as an antirheumatic and as a chelating agent in Wilson's disease. Dimethylcysteine,Mercaptovaline,beta,beta-Dimethylcysteine,Copper Penicillaminate,Cuprenil,Cuprimine,D-3-Mercaptovaline,D-Penicillamine,Metalcaptase,D 3 Mercaptovaline,D Penicillamine,Penicillaminate, Copper,beta,beta Dimethylcysteine
D011241 Prednisone A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver. Dehydrocortisone,delta-Cortisone,Apo-Prednisone,Cortan,Cortancyl,Cutason,Dacortin,Decortin,Decortisyl,Deltasone,Encorton,Encortone,Enkortolon,Kortancyl,Liquid Pred,Meticorten,Orasone,Panafcort,Panasol,Predni Tablinen,Prednidib,Predniment,Prednison Acsis,Prednison Galen,Prednison Hexal,Pronisone,Rectodelt,Sone,Sterapred,Ultracorten,Winpred,Acsis, Prednison
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D006505 Hepatitis INFLAMMATION of the LIVER. Hepatitides
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

R B Stern, and S P Wilkinson, and R Williams
D-penicillamine as maintenance therapy for active chronic hepatitis.
January 1977, Proceedings of the Royal Society of Medicine,
R B Stern, and S P Wilkinson, and R Williams
[D-penicillamine therapy in chronic aggressive hepatitis].
January 1974, Verhandlungen der Deutschen Gesellschaft fur Innere Medizin,
R B Stern, and S P Wilkinson, and R Williams
[Penicillamine D in the treatment of chronic active hepatitis].
June 1976, Orvosi hetilap,
R B Stern, and S P Wilkinson, and R Williams
[Therapy of chronic aggressive hepatitis with D-penicillamine].
June 1973, Zeitschrift fur die gesamte innere Medizin und ihre Grenzgebiete,
R B Stern, and S P Wilkinson, and R Williams
Controlled prospective trial of corticosteroid therapy in active chronic hepatitis.
April 1971, The Quarterly journal of medicine,
R B Stern, and S P Wilkinson, and R Williams
[Mesenchyma-suppressing therapy of chronically active hepatitis using D-penicillamine].
January 1975, Verhandlungen der Deutschen Gesellschaft fur Innere Medizin,
R B Stern, and S P Wilkinson, and R Williams
[Therapy of the chronic aggressive hepatitis with D-penicillamine].
January 1971, Verhandlungen der Deutschen Gesellschaft fur Innere Medizin,
R B Stern, and S P Wilkinson, and R Williams
[Results of controlled therapeutic trials of D-penicillamine in chronic hepatitis].
January 1976, Polskie Archiwum Medycyny Wewnetrznej,
R B Stern, and S P Wilkinson, and R Williams
A controlled trial of D-penicillamine therapy in primary biliary cirrhosis.
April 1977, Lancet (London, England),
R B Stern, and S P Wilkinson, and R Williams
Controlled trial of cyclophosphamide in active chronic hepatitis.
April 1979, British medical journal,
Copied contents to your clipboard!